Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients

Genes Chromosomes and Cancer

Volumn 51, Issue 7, 2012, Pages 707-716

  Slaby, Ondrej ^a,b   Redova, Martina ^a,b   Poprach, Alexandr ^a   Nekvindova, Jana ^c   Iliev, Robert ^a   Radova, Lenka ^d   Lakomy, Radek ^a   Svoboda, Marek ^a,b   Vyzula, Rostislav ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 126; MICRORNA 127 3P; MICRORNA 143; MICRORNA 145; MICRORNA 195; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84860690310     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21957     Document Type: Article

References (41)

1. Bartels CL, Tsongalis GJ. 2009. MicroRNAs: Novel biomarkers for human cancer. Clin Chem 55: 623-631.
2. Bockmeyer CL, Christgen M, Muller M, Fischer S, Ahrens P, Langer F, Kreipe H, Lehmann U. 2011. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res Treat 130: 735-745.
3. Bukowski RM. 2009. Prognostic factors for survival in metastatic renal cell carcinoma: Update 2008. Cancer 115: 2273-2281.
4. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. 2009. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158.
5. Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F. 2011. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10: 1337-1345.
6. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
7. Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, Spector Y. 2010. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12: 687-696.
8. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. 2007. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
9. Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, Gajda MR, Junker K. 2011. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 29: 367-273.
10. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X. 2008. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14: 7956-7962.
11. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS. 2010. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841.
12. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G. 2009. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
13. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X, Zhao D, Sun Q, Zeng Z, Dress A, Lin MC, Kung HF, Rui H, Liu LZ, Mao F, Jiang BH, Lai L. 2011. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
14. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. 2010. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31: 1805-1812.
15. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, Ganesan S, Levine AJ, Rathmell WK, Bhanot GV. 2010. Identifying mRNA targets of microRNA dysregulated in cancer: With application to clear cell Renal Cell Carcinoma. BMC Syst Biol 4: 51.
16. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R. 2011. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res 71: 2611-2621.
17. Margulis V, Wood CG. 2007. Update on staging controversies for locally advanced renal cell carcinoma. Expert Rev Anticancer Ther 7: 909-914.
18. Meister J, Schmidt MH. 2010. miR-126 and miR-126*: New players in cancer. Scientific World J 10: 2090-2100.
19. Murai M, Oya M. 2004. Renal cell carcinoma: Etiology, incidence and epidemiology. Curr Opin Urol 14: 229-233.
20. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M. 2008. Genome-wide microRNA expression profiling in renal cell carcinoma: Significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
21. Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M. 2011. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 150: 916-922.
22. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM. 2010. The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8: 64.
23. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T, Ito H, Oshimura M, Ochiya T. 2011. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 19: 1123-1130.
24. Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S, Zou X. 2011. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 6: e20341.
25. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. 2009. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35: 109-114
26. Powers MP, Alvarez K, Kim HJ, Monzon FA. 2011. Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping. Diagn Mol Pathol 20: 63-70.
27. Redova M, Svoboda M, Slaby O. 2009. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem Biophys Res Commun 405: 153-156.
28. Reimers M, Carey VJ. 2006. Bioconductor: An open source framework for bioinformatics and computational biology. Methods Enzymol 411: 119-134.
29. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. 2011. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 71: 6208-6219.
30. Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. 2010. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297.
31. Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. 2010. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res 29: 90.
32. Slaby O, Svoboda M, Michalek J, Vyzula R. 2009. DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma. Klin Onkol 22: 202-209.
33. Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z, Liu N. 2011. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 1389: 9-18.
34. Wang X, Wang J, Ma H, Zhang J, Zhou X. 2011. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol; DOI: 10.1007/s12032-011-9880-5
35. Weng L, Wu X, Gao H, Mu B, Li X, Wang JH, Guo C, Jin JM, Chen Z, Covarrubias M, Yuan YC, Weiss LM, Wu H. 2010. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222: 41-51.
36. White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. 2011. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br J Cancer 105: 1741-1749.
37. Wood CG. 2006. Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy. J Surg Oncol 94: 264-265.
38. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brunagel G, von Ruecker A, Muller SC, Ellinger J. 2011. Micro RNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS One 6: e25787.
39. Yi Z, Fu Y, Zhao S, Zhang X, Ma C. 2009. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136: 855-862.
40. Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM. 2011. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 59: 721-730.
41. Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q. 2010. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32: 2-9.